Literature DB >> 20488953

What is the role of somatic mutation in autosomal dominant polycystic kidney disease?

Peter C Harris1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20488953     DOI: 10.1681/ASN.2010030328

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  21 in total

1.  Smac-mimetic-induced epithelial cell death reduces the growth of renal cysts.

Authors:  Lucy X Fan; Xia Zhou; William E Sweeney; Darren P Wallace; Ellis D Avner; Jared J Grantham; Xiaogang Li
Journal:  J Am Soc Nephrol       Date:  2013-08-29       Impact factor: 10.121

2.  Third-hit signaling in renal cyst formation.

Authors:  Thomas Weimbs
Journal:  J Am Soc Nephrol       Date:  2011-04-14       Impact factor: 10.121

3.  Induced pluripotent stem cells from polycystic kidney disease patients: a novel tool to model the pathogenesis of cystic kidney disease.

Authors:  Alexis Hofherr; Michael Köttgen
Journal:  J Am Soc Nephrol       Date:  2013-09-05       Impact factor: 10.121

Review 4.  Kidney: polycystic kidney disease.

Authors:  Binu M Paul; Gregory B Vanden Heuvel
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2014-09-03       Impact factor: 5.814

5.  Reduced ciliary polycystin-2 in induced pluripotent stem cells from polycystic kidney disease patients with PKD1 mutations.

Authors:  Benjamin S Freedman; Albert Q Lam; Jamie L Sundsbak; Rossella Iatrino; Xuefeng Su; Sarah J Koon; Maoqing Wu; Laurence Daheron; Peter C Harris; Jing Zhou; Joseph V Bonventre
Journal:  J Am Soc Nephrol       Date:  2013-09-05       Impact factor: 10.121

6.  Generation of c-Myc transgenic pigs for autosomal dominant polycystic kidney disease.

Authors:  Jianhua Ye; Jin He; Qiuyan Li; Yuanyuan Feng; Xueyuan Bai; Xiangmei Chen; Yaofeng Zhao; Xiaoxiang Hu; Zhengquan Yu; Ning Li
Journal:  Transgenic Res       Date:  2013-03-30       Impact factor: 2.788

Review 7.  Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases.

Authors:  Emilie Cornec-Le Gall; Vicente E Torres; Peter C Harris
Journal:  J Am Soc Nephrol       Date:  2017-10-16       Impact factor: 10.121

8.  Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity.

Authors:  Katharina Hopp; Christopher J Ward; Cynthia J Hommerding; Samih H Nasr; Han-Fang Tuan; Vladimir G Gainullin; Sandro Rossetti; Vicente E Torres; Peter C Harris
Journal:  J Clin Invest       Date:  2012-10-15       Impact factor: 14.808

9.  The cleaved cytoplasmic tail of polycystin-1 regulates Src-dependent STAT3 activation.

Authors:  Jeffrey J Talbot; Xuewen Song; Xiaofang Wang; Markus M Rinschen; Nicholas Doerr; Wells B LaRiviere; Bernhard Schermer; York P Pei; Vicente E Torres; Thomas Weimbs
Journal:  J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 10.121

10.  STAT3 Signaling in Polycystic Kidney Disease.

Authors:  Thomas Weimbs; Jeffrey J Talbot
Journal:  Drug Discov Today Dis Mech       Date:  2013-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.